JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Insulin-like Growth Factor-1 Des(1-3) represents a modified variant of IGF-1 with enhanced receptor binding characteristics due to its truncated N-terminal structure. This peptide hormone demonstrates significant potential in cellular proliferation studies, myoblast differentiation research, and metabolic pathway investigations. The lyophilised formulation ensures optimal stability during storage while maintaining biological activity for in vitro experimental protocols.
Laboratory reconstitution requires precise methodology to preserve the structural integrity of this delicate peptide. Proper solvent selection and aseptic handling protocols ensure consistent experimental results across research applications involving cellular growth mechanisms and anabolic pathway studies.
Establish a controlled sterile environment within a laminar flow cabinet to prevent contamination during the reconstitution process. Allow the lyophilised IGF-1 DES vial to equilibrate to room temperature for approximately 15-20 minutes before handling. This temperature stabilization prevents thermal shock to the peptide structure during solvent addition.
Examine the lyophilised powder through visual inspection, confirming the presence of a white to off-white cake or powder formation. Any discoloration or unusual appearance indicates potential degradation and warrants replacement of the research material. Prepare all sterile instruments within the aseptic workspace, ensuring needle packages remain unopened until immediate use.
Bacteriostatic water provides optimal reconstitution results for IGF-1 DES due to its neutral pH characteristics and antimicrobial preservation properties. Alternatively, sterile distilled water offers suitable reconstitution capabilities for immediate-use applications. Avoid acidic or alkaline solvents that may compromise peptide stability through structural modifications.
Step 1: Sanitize the rubber stopper of the IGF-1 DES vial using a 70% isopropyl alcohol pad, allowing complete evaporation before needle insertion.
Step 2: Draw the calculated volume of bacteriostatic water into a sterile syringe, ensuring precise measurement according to desired final concentration requirements.
Step 3: Insert the needle through the vial stopper at a 45-degree angle, directing the needle tip toward the glass wall rather than directly onto the lyophilised cake.
Step 4: Slowly inject the solvent along the vial wall, allowing the liquid to gently contact the peptide powder without creating turbulence or foam formation.
Step 5: Remove the needle and syringe, then gently swirl the vial using circular motions until complete dissolution occurs. Avoid vigorous shaking or vortex mixing.
Step 6: Visually confirm complete dissolution, ensuring no visible particles or undissolved material remains in the solution.
Step 7: Transfer the reconstituted solution to appropriately labeled amber storage vials if multiple aliquots are required for research protocols.
Store reconstituted IGF-1 DES solutions at 2-8°C in amber glass containers to minimize photodegradation and maintain peptide stability. The reconstituted solution maintains optimal activity for 2-4 weeks under proper refrigeration conditions. For extended storage requirements, prepare single-use aliquots and store at -20°C, avoiding repeated freeze-thaw cycles that compromise peptide integrity.
Label all storage containers with reconstitution date, concentration, and storage conditions to ensure proper laboratory inventory management and research protocol compliance.
Element SARMs IGF-1 DES demonstrates exceptional stability in cell culture media applications, making it suitable for extended incubation studies involving myoblast proliferation and differentiation protocols. The reconstituted peptide integrates effectively with various research methodologies, including dose-response studies and time-course cellular analysis.
Consider preparing working dilutions from stock solutions to minimize handling of the primary reconstituted material, thereby preserving the integrity of the remaining research supply for future experimental protocols.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.